Fetal Fentanyl Syndrome: Unveiling a New Syndrome Linked to Fentanyl Use During Pregnancy
Dr. Karen Gripp, MD, Chief of the Division of Medical Genetics at Nemours Children’s Health in Wilmington, has been at…
Workflow Is King: Gaining Clinical Buy-In For AI In Health Care
8 Aug 2019
Forbes
“In this tech-governed era that has long been proclaimed the era of artificial intelligence (AI), one of the most promising sectors for early adoption is health care. So why is the adoption rate of AI in health care so slow? And why is it that technology experts, who typically come from either startups or big tech giants, are the driving force of innovation, rather than traditional leaders in the health care field?”
The Forbes article, discusses strategies for integrating AI into clinical workflows, emphasizing FDNA’s Face2Gene technology. Face2Gene utilizes advanced AI to analyze facial features, facilitating the expedited diagnosis of rare genetic disorders with high accuracy. The article highlights the importance of seamless integration of AI decision support tools into existing clinical workflows to gain acceptance from healthcare professionals. FDNA’s success with Face2Gene demonstrates how AI can enhance diagnostic processes, improve patient outcomes, and streamline operations.
Related articles
Continue reading
Interview with Dr. Giulia Pascolini: Unravelling the Genetic Underpinnings of Dermatological Anomalies
Dr Giulia Pascolini, an esteemed Italian M.D. and Ph.D., is currently responsible for the Genetic Counselling Service of the Istituto…
Spanish Coffin Siris Syndrome Association: Fighting for Health and Recognition
Founded in 2017, the Spanish Coffin Siris Syndrome Association is an organization dedicated to supporting families affected by this rare…